Silverarc Capital Management’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.7M | Buy |
|
|||||
|
2025
Q1 | $19.6M | Buy |
|
|||||
|
2024
Q4 | $5.19M | Buy |
|
|||||
|
2024
Q3 | $6.65M | Buy |
|
|||||
|
2024
Q2 | $6.61M | Sell |
|
|||||
|
2024
Q1 | $6.66M | Buy |
|
|||||
|
2023
Q4 | $1.37M | Sell |
|
|||||
|
2023
Q3 | $2.2M | Sell |
|
|||||
|
2023
Q2 | $6.48M | Sell |
|
|||||
|
2023
Q1 | $5.69M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $357 | Sell |
|
|||||
|
2021
Q1 | $1.28M | Buy |
|